Our results indicate that Dyrk1 inhibition reduces tau phosphorylation only in the insoluble fraction; these findings are consistent with the observation that in human AD brains Dyrk1a is associated with tau in the sarkosyl‐insoluble fraction (Ferrer et al., 2005). Here, MAPT is linked to Alzheimer disease.